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38Objective: To investigate the required area of lymph node sampling during segmentectomy, especially for seg-
mental nodes at the nonresected segments, we examined the distribution of sentinel nodes in patients with non–
small cell lung cancer who underwent segmentectomy.
Methods: Ninety-four patients with clinical T1 N0 M0 non–small cell lung cancer were treated by using segmen-
tectomy and dissection of lymph nodes with sentinel node identification using 99mTc-phytate. Anatomic locations
of the segments were classified as either anterior or posterior, and correlations of anatomic location with the dis-
tribution of sentinel nodes at the segmental nodes were then examined.
Results: Of the 94 patients, segmental nodes at both the resected and nonresected segments could be dissected in
42 patients. Segmental sentinel nodes were found at the resected segments in 27 (64%) of these 42 patients, a fre-
quency that was significantly higher than that (12/42 [29%]) seen at the nonresected segments (P¼ .001). Seven
(47%) of the 15 patients with tumors in the anteriorly located segments had segmental sentinel nodes at the non-
resected segments, a frequency that was significantly higher than that (4/24 [17%]) seen in patients with tumors in
the posteriorly located segments (P ¼ .04).
Conclusion: The lymphatic flow from the anteriorly located segment can frequently go directly to the segmental
lymph nodes of the posteriorly located segment, probably because the lobar bronchi locate at the posterior side in
the thorax. Therefore segmental lymph nodes should be dissected at both the resected and nonresected segments
during segmentectomy, especially for tumors in the anteriorly located segment. (J Thorac Cardiovasc Surg
2010;139:38-42)Earn CME credits at
http://cme.ctsnetjournals.org
In 1995, the Lung Cancer Study Group reported the results of
a prospective randomized control trial of limited resection ver-
sus lobectomy for clinical T1 N0 M0 non–small cell lung can-
cer (NSCLC) and concluded that the former was inferior to the
latter regarding local recurrence and survival.1 Local recur-
rences after segmentectomy are known to be caused by the fol-
lowing factors: (1) insufficient surgical margin, (2) missing
intrapulmonary metastasis within the same lobe, and (3) miss-
ing lymph node metastasis at the hilum, mediastinum, or both.
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The Journal of Thoracic and Cardiovascular Surgetinal lymph node stations should be submitted for intraopera-
tive frozen section examinations to confirm the intraoperative
N staging to be N0.2-6 However, it has not yet been clarified
whether segmental lymph nodes at the nonresected segments
should be dissected during segmentectomy.
Since April 2005, we have identified the sentinel node
(SN) for intraoperative N staging during segmentectomy
by using radioisotopes to target the lymph nodes submitted
for intraoperative frozen section.7 During segmentectomy,
we have endeavored to dissect segmental lymph nodes at
not only the resected segment but also the nonresected seg-
ment. In the present study, to investigate the required area of
lymph node sampling during segmentectomy, we examined
the pathologic results and the distribution of SNs, especially
at the segmental nodes of the nonresected segments.
Regarding the radioisotope tracers for SN identification, we
used 99mTc tin colloid from April 2005 to December 2006 and
have used 99mTc tin colloid since January 2007.8,9 The present
study examined patients whose SNs were identified by using
99mTc-phytate from January 2007 to December 2008.MATERIALS AND METHODS
Eligibility
The study protocol using radioisotopes for SN identification in patients
with clinical stage I NSCLC was approved by the Ethics Committee of
the Graduate School of Medical Sciences, Kumamoto University, in March
2005. Clinical staging was performed by using body computed tomographicry c January 2010
TABLE 1. Lymph node nomenclature
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SN2 node N1 node
Superior mediastinal Hilar
No. 1. Highest mediastinal No. 10. HilarAbbreviations and Acronyms
NSCLC ¼ non–small cell lung cancer
SN ¼ sentinel nodeNo. 2. Paratracheal No. 11. Interlobar
No. 3. Pretracheal No. 12. Lobar
No. 4. Tracheobronchial Intrapulmonary
Aortic No. 13. Segmental
No. 5. Botallo’s No. 14. Subsegmental
No. 6. Para-aortic
Inferior mediastinal
No. 7. Subcarinal
No. 8. Paraesophageal
No. 9. Pulmonary ligamentscanning, brain magnetic resonance imaging, and positron emission tomog-
raphy. All patients provided informed consent after fully discussing the risks
and benefits with their surgeons. Eligible patients had clinical stage IA pe-
ripheral-type NSCLC and were candidates for segmentectomy with system-
atic lymph node dissection, as reported previously.7
Patients
From January 2007 to December 2008, 147 patients with clinical stage
IA NSCLC underwent surgical treatment. Of these, segmentectomy was
planned and requested by 128 patients. Of these 128 patients, 99 received
SN identification with 99mTc-phytate, whereas the remaining 29 did not be-
cause their tumors showed ground-glass opacity and were usually stage N0
bronchioloalveolar carcinomas. Lymph node nomenclature was based on
the original lymph node map for lung cancer (Table 1).10 The pathologic
stage was based on the TNM classification of the International Union
Against Cancer.11
Administration of Radioactive Colloid
Administration of radiotracers was based on a method reported previ-
ously.7,8,12,13 Approximately 18 hours before surgical intervention, 6 to 8
mCi of 99mTc-phytate, which had been suspended in a volume of 1 to 1.5
mL, was injected into the peritumoral region. This procedure was carried
out in a room of a coregistered single photon emission computed tomogra-
phy and computed tomographic imaging (SPECT/CT).
SN Criteria
The radioactivity of the dissected lymph nodes was measured intraoper-
atively for 10 seconds with a handheld gamma probe (Navigator; Auto Su-
ture Japan, Tokyo, Japan), as reported previously.7-9 A node was defined as
an SN when the radioactivity count was greater than 10 times the back-
ground level (ie, the radioactivity on the rack where SNs were identified).
The identified SNs were submitted for intraoperative frozen section.
Operative Procedures
Under thoracotomy, segmentectomy with SN identification was per-
formed, as reported previously.7 After segmentectomy, nodal stations 10
to 13, including station 13 at the nonresected segments, were dissected
with taping of the segmental vessels and bronchi, followed by mediastinal
lymph node dissection. SNs were examined by using intraoperative frozen
sections, which were serially cut at 2 to 3 mm in thickness. Further histo-
logic examination of the dissected lymph nodes was performed with forma-
lin-fixed and paraffin-embedded sections with hematoxylin and eosin
staining. If the intraoperative frozen section of SNs showed no metastasis,
the operative procedure was completed with segmentectomy. If the frozen
sections of SNs showed metastasis, the operative procedure was converted
to lobectomy.
Classification of the Anatomic Locations of Segments
The anatomic locations of segments were classified as anterior, posterior,
and apical, as shown in Figure 1. The anterior segment of the right upper
lobe (right S3), apical anterior segment of the left upper lobe (left S3), lateral
and median segments of the middle lobe (right S4 and S5, respectively), su-
perior lingular and inferior lingular segments of the left upper lobe (left S4
and S5, respectively), and anterior segment of the bilateral lower lobes (S8)
were classified as anteriorly located segments. The posterior segment of theThe Journal of Thoracic and Cright upper lobe (right S2), apical posterior segment of the left upper lobe
(left S1þ2), and apical, lateral, and posterior segments of the lower lobe
(S6, S9, and S10, respectively) were classified as posteriorly located seg-
ments. The apical segment of the right upper lobe (S1) was classified as
the segment at the apical side.
Statistical Analysis
Differences in identification rates of SNs among lymph node stations
were analyzed for statistical significance by using the c2 test. All values
in the text and tables are presented as means  standard deviations.RESULTS
There were no complications associated with radioisotope
injection, such as bleeding or pneumothorax necessitating
tube drainage. Of the 99 patients for whom segmentectomy
with SN identification was planned, SNs could be identified
in 94 (95%; Table 2). The radioactivity of background
counted by the Navigator (Auto Suture Japan) was usually
0 or 1. The mean radioactivity of 226 SNs in the 94 patients
was 204  712 count/s (range, 10–5126 count/s). The mean
number of SNs identified was 2.4  1.3 nodes per patient.
Table 3 shows the distribution of SNs in 5 patients with path-
ologic N1 or N2 disease. SNs in these 5 patients could be
identified during the operation and were shown to have me-
tastases by examination of intraoperative frozen sections.
Two of the 5 patients (patients 1 and 2) had SNs at station
13 of the resected segments. All 3 patients with tumors in
the left upper lobe (patients 3-5) had metastatic SNs at sta-
tion 5. The operation was converted to a lobectomy for these
5 patients, except for patient 3 because of his age (ie, 81
years).
At the stations of hilum, the SNs were identified at station
10 in 22 (23%) of the 94 patients, at station 11 in 38 (40%)
patients, at station 12 in 33 (47%) patients, and at station 13
in 50 (53%) patients. Stations 13 and 12 had SNs more fre-
quently than station 10 (P< .001 and P ¼ .001, respec-
tively). The distribution of mediastinal SNs in each lobe is
shown in Table 4. The distribution was mostly lobe specific:
stations 3 or 4 for tumors in the right upper lobe, station 5 forardiovascular Surgery c Volume 139, Number 1 39
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FIGURE 1. Classification of the anatomic locations of segments: A, right
lung; B, left lung.
TABLE 2. Characteristics of patients
Mean age (y) 64  10
Sex
Male 51
Female 53
Tumor size (cm)
Mean 1.7  0.6
Range 0.7–3.0
Histologic type
Adenocarcinoma 82
Squamous cell carcinoma 11
Carcinoid 1
Tumor location
Right upper lobe 27
Right middle lobe 2
Right lower lobe 25
Left upper lobe 30
Left lower lobe 10
Pathologic TNM stage
T1 N0 M0 88
T2 N0 M0 1
T1 N1 M0 2
T1 N2 M0 3
Total 94
TABLE 3. Results of sentinel lymph node identification for patients
with pathologic N1 or N2 disease
Tumor
Patient
no. Histology
Size
(cm) Location p-TNM
Sentinel lymph
node [metastatic
lymph node]
1 AD
1 AD 3.0 RUL T1 N1 M0 12, [13]
2 Sq 2.7 RUL T1 N1 M0 [10], 12, 13
3 Ad 2.0 LUL T1 N2 M0 [5]
4 Ad 2.7 LUL T1 N2 M0 [5], 6, [10], [12]
5 Sq 2.0 LUL T1 N2 M0 [5], 12, 13
Brackets show sentinel nodes with metastasis. Ad, Adenocarcinoma; RUL, right upper
lobe; Sq, squamous cell carcinoma; LUL, left upper lobe.
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Stumors in the left upper lobe, and station 7 for tumors in the
bilateral lower lobes.
Station 13 at both the resected and the nonresected seg-
ments could be dissected in 42 of the 94 patients. In the other
52 patients, station 13 at either the resected or nonresected seg-
ment was not dissectible because it could not be visualized
during surgical intervention. Table 5 shows the correlation be-
tween the location of station 13 SNs and the locations of the
resected segments in the 42 patients. The anteriorly located
segments were resected in 15 patients, the posteriorly located
segments were resected in 24 patients, and the right S1 was re-
sected in 3 patient. The station 13 SNs were found only at the
resected segments in 18 patients, only at the nonresected seg-
ments in 3 patients, at both in 9 patients, and at neither in 12
patients. As a result, the station 13 SNs were found at the re-
sected segments in 27 (18þ9; 64%) of the 42 patients, whereas40 The Journal of Thoracic and Cardiovascular Surgethey were found at the nonresected segments in 12 (3þ9; 29%)
of the 42 patients. The frequency of station 13 SNs found at the
resected segments was significantly higher than that at the
nonresected segments (P ¼ .001). Of the 15 patients with tu-
mors in the anteriorly located segments, 7 (3þ4; 47%), patients
had station 13 SNs at the nonresected segments, the percent-
age of which was significantly higher than that (4 [17%])
seen in the 24 patients with tumors in the posteriorly located
segments (P¼ .04). Three patients with tumors in the anteri-
orly located segments had station 13 SNs only at the nonre-
sected segments.
Of the 89 patients who were completed with segmentec-
tomy at stage N0, 2 patients had tumor recurrence at thery c January 2010
TABLE 4. Sentinel nodes at the mediastinum in each lobe
Sentinel node
Tumor location Station No. of patients %
Right upper lobe 3 or 4 12/27 44
7 3/27 11
Right middle lobe 3 or 4 2/2 100
7 1/2 50
Right lower lobe 7 11/25 44
3 or 4 6/25 24
Left upper lobe 5 14/30 47
7 2/30 7
Left lower lobe 7 3/10 30
5 2/10 20
9 1/10 10
TABLE 5. Correlation between the location of station 13 sentinel
nodes and the anatomic location of segments resected
Location of station 13
sentinel nodes
Anatomic location
of segments resected
Anterior Posterior Right S1 Total
Resected segment alone 4 13 1 18
Nonresected segment alone 3 0 0 3
Both segments 4 4 1 9
Neither segment 4 7 1 12
Total 15 24 3 42
Anterior, Bilateral S3, left S4 and S5, and bilateral S8; Posterior, right S2, left S1þ2,
and bilateral S6, S9, and S10.
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The remaining 87 patients are now alive and without recur-
rence at the median follow-up of 15 months.
DISCUSSION
The present results highlight the following 3 points. First,
although the station 13 SNs were more frequently found at
the resected than at the nonresected segments, 29% of pa-
tients still had station 13 SNs at the nonresected segments.
Second, tumors in the anteriorly located segments had sta-
tion 13 SNs at the nonresected segments more frequently
than tumors in the posteriorly located segments. Finally,
SNs at the mediastinum are mostly lobe specific.
Lymphatic flow at the hilum in patients with NSCLC has
not previously been reported. The present results indicate
station 13 SNs to be found more frequently at the resected
segments than at the nonresected segments, as expected.
On the other hand, 29% of the patients still had station 13
SNs at the nonresected segments. Patients with tumors in
the anteriorly located segments had station 13 SNs more fre-
quently at the nonresected segments than those with tumors
in the posteriorly located segments. The following factors
might explain the distribution of station 13 SNs. The lym-
phatic flow around station 13 generally goes to the roots
of the lobar bronchi, which are located at the posterior side
in the thorax. Therefore lymphatic flow from the anteriorly
located segment occasionally goes directly to station 13 at
the posteriorly located segment without passing through its
own station 13. Although we have no experience of metas-
tasis recognized only at station 13 of the nonresected seg-
ment during segmentectomy, Yamanaka and colleagues14
examined the distribution of metastases at station 13 in 94
patients with small peripheral NSCLC and obtained the fol-
lowing data. Of the 10 patients with metastases at station 13,
6 had these metastases only at the tumor-bearing segments, 1
patient had metastasis only at the non–tumor-bearing seg-
ments, and 3 had metastases at both. Taking the results of
the present study and those of Yamanaka and colleagues to-The Journal of Thoracic and Cgether, we advocate that lymph node sampling at station 13
during segmentectomy be conducted not only at the resected
segments but also at the nonresected segments, especially
for tumors located in the anteriorly located segments.
Skip metastasis to the mediastinal lymph nodes has been
reported to occur in 20% to 40% of patients with
NSCLC15,16 because of some lymphatic flow going directly
to the mediastinum rather than to the hilum.17 We found that
the mediastinal SNs were mostly lobe specific (ie, upper me-
diastinal lymph nodes in tumors of the upper lobe and lower
mediastinal lymph nodes in those of the lower lobe), as re-
ported by other authors.15,16,18 Two of our 3 patients with
tumors in the left upper lobe showed skip metastasis at sta-
tion 5, which has been reported to be almost N1 station for
tumors in that lobe.15,16,18 The results of the present study
and the previous reports show that lymph node sampling
during segmentectomy should be conducted not only at
the hilum but also at lobe-specific mediastinal lymph nodes.
Although our data could not evaluate the prognostic sig-
nificance of segmentectomy with complete lymph node dis-
section because of a short follow-up period, we could show
the required area of lymph node sampling during segmentec-
tomy in patients with clinical stage IA NSCLC. To prevent
the local recurrence from lymph nodes after segmentectomy,
we recommend the complete dissection of lymph nodes at
the hilum, including those of station 13 at both the resected
and nonresected segments, especially for tumors in the ante-
riorly located segments.References
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